The phenotypic and molecular genetic features of pachyonychia congenita
- PMID: 21430705
- DOI: 10.1038/jid.2011.59
The phenotypic and molecular genetic features of pachyonychia congenita
Abstract
Pachyonychia congenita (PC) is an autosomal dominant genodermatosis caused by heterozygous mutations in any one of the genes encoding the differentiation-specific keratins K6a, K6b, K16, or K17. The main clinical features of the condition include painful and highly debilitating plantar keratoderma, hypertrophic nail dystrophy, oral leukokeratosis, and a variety of epidermal cysts. Although the condition has previously been subdivided into PC-1 and PC-2 subtypes, the phenotypic characterization of 1,000 mutation-verified PC patients enrolled in the International PC Research Registry, coordinated by the patient advocacy group PC Project, shows that there is considerable overlap between these subtypes. Thus, a new genotypic nomenclature is proposed, in which PC-6a represents a patient carrying a mutation in the K6a gene, etc. Although a rare disorder, PC represents a good model for therapy development, and international efforts are ongoing to develop and deliver siRNA, gene, correction, small molecule, and other strategies to treat this painful, disabling skin condition. The special relationship between PC Project and the PC research community has greatly accelerated the development pathway from gene identification to clinical trials in only a few years and represents a paradigm of hope for other orphan diseases.
Similar articles
-
A spectrum of mutations in keratins K6a, K16 and K17 causing pachyonychia congenita.J Dermatol Sci. 2007 Dec;48(3):199-205. doi: 10.1016/j.jdermsci.2007.07.003. Epub 2007 Aug 24. J Dermatol Sci. 2007. PMID: 17719747
-
Pachyonychia congenita in pediatric patients: natural history, features, and impact.JAMA Dermatol. 2014 Feb;150(2):146-53. doi: 10.1001/jamadermatol.2013.6448. JAMA Dermatol. 2014. PMID: 24132595
-
Clinical and pathological features of pachyonychia congenita.J Investig Dermatol Symp Proc. 2005 Oct;10(1):3-17. doi: 10.1111/j.1087-0024.2005.10202.x. J Investig Dermatol Symp Proc. 2005. PMID: 16250204 Review.
-
Novel and recurrent mutations in the genes encoding keratins K6a, K16 and K17 in 13 cases of pachyonychia congenita.J Invest Dermatol. 2001 Dec;117(6):1391-6. doi: 10.1046/j.0022-202x.2001.01565.x. J Invest Dermatol. 2001. PMID: 11886499
-
[Pachyonychia congenita. Keratin gene mutations with pleiotropic effect].Hautarzt. 1999 Jul;50(7):483-90. doi: 10.1007/s001050050947. Hautarzt. 1999. PMID: 10464680 Review. German.
Cited by
-
Novel molecular therapies for heritable skin disorders.J Invest Dermatol. 2012 Mar;132(3 Pt 2):820-8. doi: 10.1038/jid.2011.389. Epub 2011 Dec 8. J Invest Dermatol. 2012. PMID: 22158553 Free PMC article. Review.
-
Mutation p.Leu128Pro in the 1A domain of K16 causes pachyonychia congenita with focal palmoplantar keratoderma in a Chinese family.Eur J Pediatr. 2014 Jun;173(6):737-41. doi: 10.1007/s00431-013-2236-8. Epub 2013 Dec 20. Eur J Pediatr. 2014. PMID: 24357266
-
An integrated epigenetic and transcriptomic analysis reveals distinct tissue-specific patterns of DNA methylation associated with atopic dermatitis.J Invest Dermatol. 2014 Jul;134(7):1873-1883. doi: 10.1038/jid.2014.87. Epub 2014 Feb 13. J Invest Dermatol. 2014. PMID: 24739813
-
Author's Reply: Pachyonychia Congenita Type 1: Case Report and Review of the Literature.Indian J Dermatol. 2016 Nov-Dec;61(6):675. doi: 10.4103/0019-5154.193686. Indian J Dermatol. 2016. PMID: 27904190 Free PMC article. No abstract available.
-
Molecular therapeutics for heritable skin diseases.J Invest Dermatol. 2012 Nov 15;132(E1):E29-34. doi: 10.1038/skinbio.2012.9. J Invest Dermatol. 2012. PMID: 23154630 Free PMC article. Review. No abstract available.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
